Next Engineers, a global college- and career-readiness programme working to increase the opportunities for young people in ...
From GPS to innovations in computing and optics, technologies developed for space research touch nearly every aspect of ...
Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...
(Reuters) -Pfizer (PFE) said on Monday it would acquire drug developer Metsera (MTSR) in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback